secwatch.observer — SEC 8-K summary
======================================

Issuer:     TENET HEALTHCARE CORP (THC)
CIK:        0000070318
Form:       8-K
Filed at:   2023-02-09T23:59:59+00:00
Accession:  0000070318-23-000006
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenet Q4 net income $102M ($0.92 diluted EPS), FY2023 Adj. EBITDA guidance $3.16B-$3.36B
--------------------------------------------------------------------------------

- Q4 2022 net income from continuing ops $102M ($0.92 diluted EPS) vs $250M ($2.30) a year ago; adjusted diluted EPS $1.96 vs $2.70.
- Consolidated Q4 Adj. EBITDA $897M (incl $40M grant income) vs $1.017B; Ambulatory Adj. EBITDA ex-grant grew 18.7% to $407M.
- FY2023 outlook: Adj. EBITDA $3.16B-$3.36B, adjusted diluted EPS $4.68-$5.85; net operating revenues $19.7B-$20.1B.
- Repurchased 5.9M shares for $250M in Q4; entered deal to sell San Ramon Regional Medical Center for $142.5M (close expected 2023).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/70318/000007031823000006/0000070318-23-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/70318/000007031823000006/thc-20230209.htm
  HTML page:      https://secwatch.observer/filing/0000070318-23-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer